Oracle founder, CEO and technical leader Larry Ellison is redirecting his charitable approach, which has failed in recent years, to end the COVID-19 crisis, according to newsgroup Recode.
The technology tycoon, with $70 billion in his call and a declared willingness to distribute some of that fortune, has begun liberating at the Larry Ellison Foundation in London to “focus” his money and philanthropic power on the existing pandemic, Recode reported Wednesday. up to an email shared through a charity that has already won a grant from the foundation.
Ellison will update the organization with what Recode describes as a new “medical philanthropy” he is building. Oracle declined to comment on the report.
Ellison already has resources true to the fight against the virus that has killed much of the world economy and killed more than 180,000 people in the United States alone.
After the pandemic erupted in March, he put Oracle engineers to work to expand a “therapeutic system”: a real-world knowledge repository to tell the paintings of the US Department of Health and Human Services. But it’s not the first time And affiliated health care organizations that fight COVID-19.
This assignment provides researchers with aggregate knowledge, which is not owned by Oracle, about remedy decisions with commercially available drugs, the effects of those remedies, and the effects of continuous monitoring of viral symptoms.
This database contributes to studies that are now monitored through institutional review committees and study organizations that can when and where to publish the results.
Ellison has begun replacing his foundation’s goals in 2018, but the existing crisis has led to the replacement, of course, after two years of work, according to Recode.
Ellison’s coronavirus credentials were also questioned through a New York Times article published in April, reporting that he was one of the first to raise hopes with President Donald Trump that hydroxychloroquine, an antimalarial, may be an effective treatment.
In a phone call in mid-March, Ellison talked about the possibility of using hydroxychloroquine, which is being tested as a component of a drug cocktail, to treat patients with the new disease.
Trump has promoted the drug for months even though there is no evidence of its effectiveness and fears it could jeopardize the fitness of other people with problems downtown.
At a White House Coronavirus Briefing in April, Trump continually suggested patients ask their doctors to prescribe the untested remedy, including asking, “What do you have to lose?”
A recent study published in Clinical Microbiology and Infection, the official journal of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), showed no evidence of a decrease in mortality rates in patients with COVID-19 taking hydroxychloroquine, and a 27% increase in mortality. for those who combined it with the antibiotic azithromycin.
The 10 new features of 2020 (so far)
Transit Wireless with AT
Power Play: your X-factor for navigating the new standard
LOOK: Fred Voccola, CEO of Kaseya, explains how “our platform is designed in particular to meet today’s challenges
New Google Cloud hires SAP, Blue Yonder, US Bank